UPMC reported revenues of $29.9 billion in the 12 months ended Dec. 31, up from $27.7 billion in 2023. Net patient service revenues were $12.2 billion, up from $11.2 billion in the prior year. Insurance enrollment revenues were $15.1 billion, up from $14.3 billion.
Operating expenses totaled $30.1 billion in 2024, up from $27.9 billion in 2023. Salaries, professional fees and employee benefit costs totaled $10 billion, up from $9.7 billion. Insurance claims expenses reached $11.2 billion, up from $10.1 billion. Supplies, purchased services and general expenses were $8.2 billion, up from $7.4 billion.
UPMC said in the report that its health plan has seen increased medical use and rising pharmacy costs, which include expenses for GLP-1 drugs.
As of Dec. 31, the system had 93 days of cash on hand, down from 109 on the same date in 2023.
After accounting for nonoperating items, such as investment returns, UPMC reported a net loss of $14.7 million, an improvement from a net loss of $30.1 million in 2023.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
